Alexander A Santini - Net Worth and Insider Trading
Alexander A Santini Net Worth
The estimated net worth of Alexander A Santini is at least $24,259 dollars as of 2024-11-08. Alexander A Santini is the EVP and CCO of Lexicon Pharmaceuticals Inc and owns about 18,661 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $24,259. Details can be seen in Alexander A Santini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexander A Santini has not made any transactions after 2019-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alexander A Santini
Alexander A Santini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander A Santini owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Alexander A Santini’s form 4 insider trades.
Insider Ownership Summary of Alexander A Santini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2019-09-18 | EVP and CCO |
Alexander A Santini Latest Holdings Summary
Alexander A Santini currently owns a total of 1 stock. Alexander A Santini owns 18,661 shares of Lexicon Pharmaceuticals Inc (LXRX) as of September 18, 2019, with a value of $24,259.
Latest Holdings of Alexander A Santini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2019-09-18 | 18,661 | 1.30 | 24,259 |
Holding Weightings of Alexander A Santini
Alexander A Santini Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander A Santini has made a total of 0 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 4,500 shares on September 18, 2019, which cost Alexander A Santini around $15,120.
Insider Trading History of Alexander A Santini
- 1
Alexander A Santini Trading Performance
GuruFocus tracks the stock performance after each of Alexander A Santini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander A Santini is 13.92%. GuruFocus also compares Alexander A Santini's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander A Santini within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alexander A Santini's insider trading performs compared to the benchmark.
Performance of Alexander A Santini
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.06 | | | | | |
| Relative Return to S&P 500(%) | 13 | | | | | |
Alexander A Santini Ownership Network
Ownership Network List of Alexander A Santini
Ownership Network Relation of Alexander A Santini
Alexander A Santini Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Alexander A Santini is the EVP and CCO of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Alexander A Santini made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Alexander A Santini Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander A Santini. You might contact Alexander A Santini via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
